Clinical Characteristics of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in North Indian Population of HIV/AIDS Patients Receiving HAART
Table 7
Comparison of characteristics between HIV-TB patients without and with TB-IRIS and HIV patients with ART associated TB.
No TB-IRIS
TB-IRIS
ART-associated TB
()
()
()
Age (yrs)
37 ± 10
31 ± 7
35 ± 15
Sex (% male)
80
80
50
BMI (kg/m2)
19 ± 5
18 ± 3
19.4 ± 4
ATT-ART (days)
32 (21–70)
20 (18–27)
—
ART-IRIS (days)
—
73 (6–84)
37 (7–88)
CD4 (cells/l)
136 (70–225.75)
167 (118–193)
132 (57.25–182.75)
Increase in CD4 (cells/l)
89 (32.25–144.75)
229 (61–283)
161 (129–316)
Increase in CD4 (%)
57.6 (24–181)
119 (63.5–207)
160 (72–369)
VL (log10 copies/ml)
5.21 (4.76–5.65)
5.49 (5.18–5.63)
5.28 (4.95–5.51)
Decrease in VL (log10 copies/ml)
5.19 (4.76–5.63)
5.49 (5.18–5.63)
5.13 (4.87–5.39)
Decrease in VL (%)
99.58 (98.85–99.9)
99.93 (99.91–99.97)
99.91 (99.84–99.93)
BMI: body mass index; ATT: antituberculosis treatment; ART: antiretroviral treatment; VL: viral load Age and BMI are presented as mean ± SD; gender as % of male and ATT-ART gap, ART-IRIS gap, CD4 cell counts and viral load as median and IQR.
